• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Emerg Infect Dis . Early Circulation of SARS-CoV-2, Congo, 2020

tetano

Editor, Senior Moderator
Emerg Infect Dis


. 2022 Feb 18;28(4).
doi: 10.3201/eid2804.212476. Online ahead of print.
Early Circulation of SARS-CoV-2, Congo, 2020

Novy Charel Bobouaka Bonguili, Matthieu Fritz, Hosanna Lenguiya, Pembe Issamou Mayengue, Félix Koukouikila-Koussounda, Louis Régis Dossou-Yovo, Cynthia Nkoua Badzi, Eric M Leroy, Fabien R Niama
Free article

Abstract

To determine when severe acute respiratory syndrome coronavirus 2 arrived in Congo, we retrospectively antibody tested 937 blood samples collected during September 2019-February 2020. Seropositivity significantly increased from 1% in December 2019 to 5.3% in February 2020, before the first officially reported case in March 2020, suggesting unexpected early virus circulation.

Keywords: 2019 novel coronavirus disease; COVID-19; Central Africa; Luminex; Republic of Congo; SARS-CoV-2; coronavirus disease; microsphere immunoassay; respiratory infections; retrospective study; serology; severe acute respiratory syndrome coronavirus 2; viruses; zoonoses.
 
Back
Top Bottom